Jing Fu

2.2k total citations · 2 hit papers
41 papers, 1.8k citations indexed

About

Jing Fu is a scholar working on Molecular Biology, Plant Science and Immunology. According to data from OpenAlex, Jing Fu has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Plant Science and 9 papers in Immunology. Recurrent topics in Jing Fu's work include Phytochemistry and biological activity of medicinal plants (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Dermatology and Skin Diseases (5 papers). Jing Fu is often cited by papers focused on Phytochemistry and biological activity of medicinal plants (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Dermatology and Skin Diseases (5 papers). Jing Fu collaborates with scholars based in China, United States and Netherlands. Jing Fu's co-authors include Xingbin Yin, Xiaoxv Dong, Jian Ni, Longtai You, Longfei Lin, Xuechun Li, Sali Cao, Yawen Zeng, Yi Liu and Chunjing Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Dental Research.

In The Last Decade

Jing Fu

38 papers receiving 1.7k citations

Hit Papers

Emodin: A Review of its Pharmacology, Toxicity and Pharma... 2016 2026 2019 2022 2016 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Fu China 16 670 623 365 258 216 41 1.8k
Hee‐Sung Chae South Korea 28 496 0.7× 1.0k 1.6× 314 0.9× 230 0.9× 206 1.0× 98 2.1k
Lih-Geeng Chen Taiwan 31 1.0k 1.5× 1.1k 1.8× 482 1.3× 424 1.6× 133 0.6× 74 2.9k
Ching‐Hsein Chen Taiwan 25 333 0.5× 903 1.4× 325 0.9× 175 0.7× 90 0.4× 57 2.0k
Jeremy J. Johnson United States 26 480 0.7× 1.1k 1.8× 238 0.7× 185 0.7× 136 0.6× 75 2.6k
Pratibha Singh India 26 500 0.7× 754 1.2× 293 0.8× 132 0.5× 161 0.7× 75 2.4k
A. Helen India 29 541 0.8× 665 1.1× 258 0.7× 340 1.3× 198 0.9× 61 2.0k
El‐Shaimaa A. Arafa Egypt 25 261 0.4× 789 1.3× 275 0.8× 266 1.0× 161 0.7× 63 2.1k
Sherif T. S. Hassan Czechia 27 301 0.4× 770 1.2× 296 0.8× 205 0.8× 259 1.2× 51 2.1k
Xiaobin Jia China 31 338 0.5× 1.2k 2.0× 508 1.4× 332 1.3× 130 0.6× 128 2.5k

Countries citing papers authored by Jing Fu

Since Specialization
Citations

This map shows the geographic impact of Jing Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Fu more than expected).

Fields of papers citing papers by Jing Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Fu. The network helps show where Jing Fu may publish in the future.

Co-authorship network of co-authors of Jing Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Fu. A scholar is included among the top collaborators of Jing Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Fu. Jing Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jing, Jing Fu, Xin Geng, & Hongyang Wang. (2025). Foundation models in clinical oncology: Progresses and perspectives. Cancer Letters. 639. 218220–218220. 1 indexed citations
2.
Liu, Chunliang, Xiang Wang, Erdong Liu, et al.. (2025). Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution. Journal of Hematology & Oncology. 18(1). 66–66. 1 indexed citations
3.
Fu, Jing, et al.. (2024). Shikonin-loaded PLGA nanoparticles: A promising strategy for psoriasis treatment. Heliyon. 10(11). e31909–e31909. 5 indexed citations
4.
Ni, Boran, Yi Liu, Mengru Cai, et al.. (2022). Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 261. 109430–109430. 19 indexed citations
5.
Liu, Jia, Qiu Wang, Jing Fu, et al.. (2021). Increased Prolactin is an Adaptive Response to Protect Against Metabolic Disorders in Obesity. Endocrine Practice. 27(7). 728–735. 12 indexed citations
6.
Qi, Cong, Yujiao Meng, Jingxia Zhao, et al.. (2021). Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells. Phytomedicine. 95. 153864–153864. 12 indexed citations
8.
Tian, Hao, et al.. (2020). Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Wang, Yan, Ping Li, Jing Fu, et al.. (2020). Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production. Journal of Leukocyte Biology. 108(1). 267–281. 20 indexed citations
10.
11.
Wang, Yan, Lu Zhang, Jing Fu, et al.. (2019). Acupuncture Needling, Electroacupuncture, and Fire Needling Improve Imiquimod-Induced Psoriasis-Like Skin Lesions through Reducing Local Inflammatory Responses. Evidence-based Complementary and Alternative Medicine. 2019. 1–9. 18 indexed citations
12.
You, Longtai, Xiaoxv Dong, Boran Ni, et al.. (2018). Triptolide Induces Apoptosis Through Fas Death and Mitochondrial Pathways in HepaRG Cell Line. Frontiers in Pharmacology. 9. 813–813. 34 indexed citations
13.
Dong, Xiaoxv, Jing Fu, Xingbin Yin, et al.. (2017). Induction of Apoptosis in HepaRG Cell Line by Aloe-Emodin through Generation of Reactive Oxygen Species and the Mitochondrial Pathway. Cellular Physiology and Biochemistry. 42(2). 685–696. 51 indexed citations
14.
Dong, Xiaoxv, Chunjing Yang, Guanling Xu, et al.. (2016). Chemical Constituents from Daphne giraldii Nitsche and Their Contents Simultaneous Determination by HPLC. Evidence-based Complementary and Alternative Medicine. 2016(1). 9492368–9492368. 12 indexed citations
15.
Cao, Shuhua, Lili Feng, Xingbin Yin, et al.. (2014). Simultaneous Determination of Typhaneoside and Isorhamnetin-3-O-Neohesperidoside in Rats After Oral Administration of Pollen Typhae Extract by UPLC-MS/MS. Journal of Chromatographic Science. 53(6). 866–871. 15 indexed citations
16.
Wang, Xinzhi, Zhenzhou Jiang, Jing Fu, et al.. (2014). Interleukin-17 mediates triptolide-induced liver injury in mice. Food and Chemical Toxicology. 71. 33–41. 43 indexed citations
17.
Fu, Jing, Xiaojie Xu, Lei Kang, et al.. (2014). miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2. Biochemical and Biophysical Research Communications. 445(2). 314–319. 69 indexed citations
18.
Fu, Jing, Xinzhi Wang, Lixin Sun, et al.. (2014). KU004 induces G1 cell cycle arrest in human breast cancer SKBR-3 cells by modulating PI3K/Akt pathway. Biomedicine & Pharmacotherapy. 68(5). 625–630. 8 indexed citations
19.
Qu, Changhai, Jian Ni, Hui Zhang, et al.. (2012). Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia–reperfusion. Drug Development and Industrial Pharmacy. 39(9). 1291–1295. 9 indexed citations
20.
Huang, Ting, Liu C, Shi-Bing Su, et al.. (2000). [Analysis on the characteristic and trend of AIDS epidemics in Shandong].. PubMed. 21(5). 338–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026